Rejected at 9:50 p.m. Oct, 31, 2023 ] by dollajas
Author: northo
Related Note: 1501987087158
Rationale for change

CDC guidelines were updated over the past couple years, doxy is now preferred over azithro given evidence of superior efficacy

Rejection reason

i don't like making decisions based off of CDC guidance alone - since that has never correlated strongly with practice questions. also this source seems to indicate that the treatment regimen would be more complicated depending on route of transmission and sex of the individual... resubmit if you see a uworld or amboss change to this effect please.

Text Text
Extra
Empty field
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid


Sketchy




Watch Chlamydia trachomatis, Chlamydophila pneumoniae & Chlamydophila psittaci
Sketchy 2


Watch Urethritis in Males
Sketchy Extra


Watch Macrolides
Picmonic
Empty field
Pixorize

Physeo
Empty field
Bootcamp
Watch associated Bootcamp video - Atypical Bacteria: Chlamydia Trachomatis Serotypes and Disease Variants

Watch associated Bootcamp video - Atpyical Bacteria: Chlamydia Pneumoniae and Psittaci

Watch associated Bootcamp video - Macrolides

Watch associated Bootcamp video - Tetracyclines and Derivatives
OME

Additional Resources
Empty field
One by one
Empty field
#AK_Step3_v12::#UWorld::12585 #AK_Step1_v12::#Bootcamp::Microbiology::16_Atypical_Bacteria::03_Chlamydia_Pneumoniae_and_Psittaci #AK_Step1_v12::#SketchyMicro::01_Bacteria::10_Gram-indeterminate_Bacteria::01_Chlamydia_trachomatis,_Chlamydophila_pneumoniae_&_Chlamydophila_psittaci #AK_Step1_v12::#Physeo::06_Micro::02_Bacteria::47_Chlamydia_Trachomatis,_Chlamydophila_Pneymoniae_&_Chlamydophila_Psittaci #AK_Step1_v12::#Bootcamp::Microbiology::36_Antibiotics::14_Macrolides #AK_Step1_v12::^Other::^HighYield::1-HighYield #AK_Step1_v12::#Pixorize::04_Microbiology::05_Bacteria-Gram_Negative::28_Chlamydia_trachomatis #AK_Step1_v12::#FirstAid::03_Microbiology::02_Clinical_Bacteriology::46_Chlamydiae #AK_Step1_v12::#FirstAid::03_Microbiology::06_Systems::13_Sexually_Transmitted_Infections #AK_Step2_v12::#AMBOSS::830O4f #AK_Step3_v12::#UWorld::5478 #AK_Step2_v12::#B&B::08_Infectious_Disease::04_Other_Topics::02_Sexually-transmitted_Infections #AK_Step1_v12::#UWorld::Step::6814 #AK_Step2_v12::#AMBOSS::AXaR0j #AK_Step1_v12::#Bootcamp::Microbiology::16_Atypical_Bacteria::02_Chlamydia_Trachomatis_Serotypes_and_Disease_Variants #AK_Original_Decks::Step_1::Lolnotacop::Bugs #AK_Step1_v12::#SketchyPharm::07_Antimicrobials::02_Inhibitors_of_Bacterial_Protein_Synthesis::02_Macrolides #AK_Step1_v12::#OME::Clinical::Internal_Medicine::Infectious_Disease #AK_Step2_v12::#SketchyIM::09_Infectious_Disease::03_GU_Infections::03_Urethritis_In_Men #AK_Step1_v12::#UWorld::Step::6781 !AK_UpdateTags::Step1decks::Lolnotacop::Bugs #AK_Step1_v12::#Bootcamp::Microbiology::36_Antibiotics::13_Tetracyclines_and_Derivatives #AK_Step1_v12::#B&B::13_Infectious_Disease::02_Bacteria::05_Other_Gram_Negatives #AK_Step1_v12::#UWorld::COMLEX::25257